Member Info for gixer

Psilly Migrain will be an interesting one as I am unsure if Amanita Muscaria is GRAS approved in the US.
:)
https://en.wikipedia.org/wiki/Amanita_muscaria

and another in the pipeline.
Coming soon!
https://postimg.cc/ft12035T

DkmedicFlow from Poland.

https://www.facebook.com/dkmedicpl/photos/a.827249203996277/4617302411657585/

https://sklep.dkmedic.pl/pl/p/DkmedicFlow/101?fbclid=IwAR1ZK_3ab-aLKHhsiEhQh7xteJa0mwl_9MBzxFeTd2y2MphYxhjelG-6MLI

Happy New Year all.

RE: "So it appears ff is in this capsule"

It looks like IF is pointing us in that direction although I cant find any evidence as yet to FF being used in this version of the "Personalised Customised Vitamin Concept Product"
Worth keeping an eye on the development of this. :)

We have been working with By-Health for 5 years of Fruitflow.
Firstly they were going to launch a product(s)
Then decided Blue Cap for Fruitflow would be better.
Now working on regulatory submissions to change the health claim register.
Then there is the future collaboration which may result in the development and approval of Fruitflow as a drug.

By-Health having made a significant investment in eight separate studies in China, at its sole expense, in support of the Fruitflow based product.
Sounds like they are developing Fruitflow to get the best return possible on there significant investment and the above decisions wouldn't have been taken on a whim just to change there mind at the last minute.

Just wonder how many million Yuen they have spent so far.

As of 30 September 2021 there was £982k in the bank so unless something spectacular happens then I cant see the need for any fund raising in the next couple of years.

https://www.lse.co.uk/news/PXS/provexis-revenue-drops-on-pandemic-related-market-disruptions-wxqp8yekzu2kt25.html

Well no big surprises.
Loss from operations down 29% to £145k even though, as expected, revenue from DSM was down due to short term lockdowns and other COVID-19 disruptions.
Fruitflow+ Omega-3 revenue up 34% but not much detail on the Chinese distributor.
Everything seems to be on track.

The sp is showing 0.76p which is bellow the bid.
Don't think the mid has changed.

Nazir, you could also say. Why has it been positive for the past 3 years?
Last year temporary measures were introduced, due to Covid, to allow delayed publication of half-yearly reports and we were notified that they would be delayed till January 2021.

Explanations of Dr. Zamanzadeh, Endocrinologist, Endocrinologist and Metabolist and Managing Director of East Tehran Diabetes Association @ dr.zamanzadeh Regarding the importance of preventing cardiovascular and cerebrovascular problems and its risk factors. The importance of consulting a doctor regularly. In individuals
https://www.instagram.com/p/CYDyP1ahUB_/

Not sure why you would want DSM or By-Health to buy us out before BH get Regulatory clearance in China for Fruitflow.
Blue Cap and a new permitted health function claim not to mention development and approval of Fruitflow as a drug would, IMO, add considerable value once achieved. I doubt I would accept any offer ATM.
As for any other questions, why not wait a couple of days till the interim results are released.

As I have a few moments before the festivities take off I thought I would share this one.

"A human subject research: the effect of By-health Fruitflow tablets on platelet aggregation"
Date of Registration:2021-12-15
http://www.chictr.org.cn/showprojen.aspx?proj=129186

There has been human studies done on Fruitflow and platelet aggregation in China before so I am not sure of the exact differences on this one but it seems to be a Cohort study instead of a Parallel study and is to evaluate the effect of FF over 30-day period and possibly to measure different outcomes from the the previous studies.

Anyway, Have a great day all.

and this one is by Dr. Khosroshahi - Diabetologist - about the primary prevention of cardiovascular disease risks by lifestyle modification.
Pity they are not in English but you get the idea.
https://www.instagram.com/p/CXndLZYl-Tt/

Dr_Horrible, RE: I also think that FF could be recommended by the government for primary prevention of CVD, which would be amazing!

You might find this recent webinar from Vestolux interesting. Although I haven't downloaded the actual webinar (might not be in English) the powerpoint presentation is interesting.

Webinar Tachra Pharmed Company was held on December 17th with the presence of professors, Dr. Estefami, Dr. Nikoosakhen, Dr. Zamanzadeh, and Dr. Riahi.
This program was held in collaboration with Iranian Diabetes Association and Gabric Diabetes Association in order to raise attention to the primary causes of cardiovascular diseases.

You can view the offline video of the program by clicking on the link below
https://lnkd.in/dK6qfpYt
Username: vestolux
Password: vestolux

Vestolux have been pretty active with webinars etc and here is the most professional bodybuilder in Iran on the vestolux stand talking about ..... errr something :)
https://www.instagram.com/p/CXsqlSmoHoW/

Dr_H RE: Anything else?
Revenue from FF+O from the Chinese Distributor.
Info on By-Health development and approval of Fruitflow as a drug
Promotion of Fruitflow benefits against the effects of Covid-19 due to increased consumer interest in this area.

Alfista, that question maybe easier to answer after the interim results which should be released within the next 6 trading days but yes, as soon as revenue is flowing from By-Health, at least, then I foresee a share price far north of what it is at the moment.
IMO DYOR etc etc.

Hi THEDON,
Nice to see you back.
I totally agree that (IMO) we will see Fruitflow included in a customised Precision Nutrition capsule in the future but if you are looking for connections then look no further than the main man in the article.
Felix "Zhang Xuguang, Executive Dean of China By-Health Nutrition and Health Research Institute and Director of Science and Technology Center"
Not much you could tell him about Fruitflow :)

"Dr Xuguang (Felix) Zhang obtained his
PhD in Human Nutrition at the Rowett
Institute in 2013. Before he joined in ByHealth, he worked for over 9 years on
medical/functional food development for
FRDC Fonterra (NZ), University of
Aberdeen, Science in Sport Plc, and
Provexis Plc. He led scientific research
projects in metabolic health and
cardiovascular health when working as a
Research Fellow and Honorary
Researcher at the Rowett Institute. He
and his team at Provexis Plc delivered
their core functional ingredient FruitFlow,
which won the first new health claim in
Europe under the Article 13.5 EFSA. Dr
Zhang is a Registered Nutritionist (Nutrition Science) in the UK."
https://www.abdn.ac.uk/rowett/documents/RINH_Invited_Speaker_Form-China_Symposium_AUG2018.pdf

Welcome aboard Xpub.

A delayed trade for 2 Mil now showing as well.